ArticleFrontiers in immunology2022

Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors.

Nazanin Tatari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.